Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, T-Cell, Peripheral × Lenalidomide × Clear all

Phase

Phase 2 3 Phase 1/2 3 Phase 1 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 9 Peripheral Nervous System Diseases 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1

Interventions

VAP-cyclo protocol 2 apatinib 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lenalidomide 1 Gemcitabine 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04040491 2020-05-12

PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

Zhengzhou University

Phase 4 Unknown

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡